JT
Joy Tang
Physician · Ohiohealth
Credentials: · · · · · ·
History
2023–PresentOhiohealth · Columbus Oncology Associates Inc
Research
Erlotinib resistance in lung cancer: current progress and future perspectives
Frontiers in Pharmacology · 2013 · First of 5 authors · 58 citations
Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas
npj Precision Oncology · 2022 · 14 citations
Expert Review of Anticancer Therapy · 2022 · 12 citations
- AA
3 papers · 3 as a resident

2 papers
- AA
1 paper
- AD
1 paper

1 paper
- CH
1 paper

1 paper

1 paper



